Why Our Mold Treatment Approach Minimizes Supplements

The average mold illness patient we talk to has already tried glutathione, NAC, liposomal vitamin C, liver support, and antifungals. Sometimes all at once. From the patient's perspective, that's not irrational. When you're sick and nobody has given you clear answers, more interventions feel safer than fewer.

But mold toxicity doesn't appear to respond to volume. The leading explanation points to one specific intervention at one specific point: the enterohepatic loop where your liver filters biotoxins into bile, sends that bile to your gut, and your gut reabsorbs over 90% of it right back. The toxins ride along each cycle. A single prescription binder (colesevelam, prescribed off-label) grabs those toxins in the gut before reabsorption. That's the suspected mechanism. And it's why MoldCo's approach starts with fewer supplements, not more.

The supplement stack trap

When you take 10 things at once, you can't tell what's helping. You can't tell what's causing a reaction. And you can't tell what to drop.

One patient in r/CIRS captured the pattern perfectly:

"If you've tried everything, from supplements to medications to neural retraining..." — Reddit user

Each new recommendation adds to the pile. Nobody ever says "stop taking that one." The stack just grows. And it's not cheap. One MoldCo patient described it before finding us: "I was on so many supplements, probably $10,000 a year's worth of supplements, and I didn't feel any better."

The reason the stack keeps growing is the recirculation loop itself. Antioxidants and liver support get layered on top of a problem they don't actually stop. Stacking them on top of that ongoing recirculation is like mopping the floor while the faucet's still running.

"I struggled for years with chronic symptoms that other doctors wanted to give me band-aid solutions for, but with MoldCo, I actually got to the root cause." — MoldCo patient

The fix isn't more bottles on your counter. It's interrupting that loop. And that's where MoldCo's approach starts: with the mechanism, not the symptoms.

Three phases, each with a single target

The protocol has three phases. Each one targets a specific problem, in order. You don't start everything at once.

Phase 1: Detox (binder therapy)

Colesevelam is an FDA-approved bile acid sequestrant, originally designed for cholesterol management and type 2 diabetes, now prescribed off-label by CIRS-trained clinicians to bind biotoxins in the digestive tract.

It works inside your gut. The molecule carries a net positive electrical charge, which lets it attract and bind negatively charged biotoxin molecules in your bile. Once bound, those toxins can't re-enter your bloodstream through the enterohepatic circulation pathway. They're excreted instead.

A double-blinded, placebo-controlled study confirmed that cholestyramine's (the original bile acid sequestrant) only relevant function is "enhancing elimination of substances accumulated in bile by preventing reabsorption during enterohepatic recirculation." Colesevelam is the better-tolerated alternative. Participants on cholestyramine showed significant improvement. Those on placebo did not.

Your clinician may also recommend a low-amylose diet and omega-3 dosages as supportive measures during this phase. These are adjuncts, not the primary treatment.

Phase 2: Clear (nasal therapy)

Once you're stable on the full binder dose, the next step addresses suspected MARCoNS (Multiple Antibiotic Resistant Coagulase Negative Staphylococci), a colonization in the nasal passages that can keep inflammation going even after biotoxin removal. Your provider orders EDTA nasal spray, a targeted therapy used off-label to disrupt biofilms. (EDTA is ordered, not prescribed. It's not a standard Rx.)

Phase 3: Repair (neuroimmune restoration)

The final phase uses VIP (Vasoactive Intestinal Peptide) nasal spray to help restore neuroimmune balance. VIP is a naturally occurring peptide that's often low in patients with mold-related illness. Your clinician evaluates this step on a case-by-case basis.

That's the complete treatment. No supplementation phase. Where other approaches layer 10 to 15 products from day one, this protocol sequences each step so you can evaluate it on its own signal. Fewer variables means faster clarity about what's actually working.

"I received my results because they came with a clear guide that explained what everything meant and what steps I needed to take next." — MoldCo patient

For a deeper walkthrough of each phase, see the complete CIRS treatment roadmap or the Shoemaker Protocol roadmap. If you're considering this approach, you can start your evaluation with a MoldCo provider.

The evidence, and where it falls short

The Shoemaker Protocol is the only treatment model with documented clinical results for CIRS in peer-reviewed literature. A 2024 systematic review found it described in 11 of 13 articles reviewed, with most treatment steps costing $100 or less per month. MoldCo's treatment is guided by this protocol.

The foundational evidence comes from a 2006 study by Shoemaker and House: a double-blinded, placebo-controlled trial showing that cholestyramine produced significant improvement compared to placebo. The binding mechanism is the leading explanation for why it works, based on what we know about enterohepatic recirculation.

One honest caveat: that trial tested cholestyramine, not colesevelam. Colesevelam is prescribed off-label based on shared mechanism and clinical experience, but the double-blinded data is for cholestyramine specifically.

Why not natural binders?

Activated charcoal and bentonite clay can bind certain mycotoxins in lab settings. But their real-world performance is inconsistent. A 2017 comparative study found bentonite clay reduced aflatoxin B1 in liver tissue by 41 to 87%. Against ochratoxin A, both clay and charcoal showed only partial to non-significant protection. Performance depends entirely on which toxin you're dealing with.

And there's a deeper problem. As one clinician specializing in mold illness explained: natural binders like bentonite clay and humic acid can bind mycotoxins, but they "don't effectively decrease the inflammatory blood markers typically elevated in cases of mold illness. This is because the disease is caused by more than the mycotoxins alone." Actinomycetes, microbial VOCs, endotoxins, allergens, and spore fragments may all play a role.

That's why MoldCo doesn't rely on natural binders: the lack of supportive data and minimal observed efficacy compared to prescription binders for mold toxicity. For more on why testing approaches matter, see what urine mycotoxin tests actually show.

What this protocol doesn't claim to do

The protocol doesn't address every dimension of recovery. Nervous system regulation, sleep quality, stress management, and mental health support can be real factors for some patients. Some people in the CIRS community have explored nervous system work as a complement to treatment, though not everyone needs it.

Supplements sometimes fill a symbolic role here, providing a sense of agency when the core protocol feels narrow. MoldCo's scope is intentionally focused on what has the strongest mechanistic evidence. But it doesn't claim to be the only thing you'll ever need.

Some patients may need additional interventions beyond the three phases, evaluated case by case. And the timeline varies: most patients work through the protocol in 6 to 12 months, but individual results differ. For more on mold illness testing options, see our testing guide.

Even with these boundaries, the structured approach gives you something most supplement stacks can't: a way to tell what's actually working.

"Their testing process is straightforward, their reports are actionable, and their guidance has genuinely changed the way I understand and manage my health." — MoldCo patient

Common questions

What natural binders work for mold illness?

Activated charcoal and bentonite clay can bind certain mycotoxins in lab settings. But binding performance varies dramatically by toxin type: strong against some, negligible against others. And binding mycotoxins alone doesn't address the full inflammatory picture in mold illness, which involves more than mycotoxins.

MoldCo doesn't use natural binders because the clinical data for mold toxicity treatment doesn't support them as primary interventions. The other reason is simpler: the binder-based protocol already has documented clinical results without supplementation. In the Shoemaker/House trial, cholestyramine alone produced significant improvement — no supplement stack required. If you're currently using charcoal or clay, it's worth discussing with a clinician who understands the full picture.

Do I need glutathione, NAC, or liver support supplements for mold?

These are among the most commonly recommended supplements in the mold illness space. The logic sounds reasonable: support your liver, help your body detoxify.

But the mechanism of mold toxicity doesn't require them. The core issue is biotoxins recirculating through your gut, not a nutrient deficiency. A prescription binder interrupts that recirculation directly. Once the toxin load drops, the inflammatory cascade can start to quiet down on its own.

You're not wrong for having tried them. The supplement approach fills a real gap when people can't access clinical care. The question is whether the supplements are addressing the mechanism or just managing downstream symptoms.

How much does the minimal-supplements approach cost compared to supplement protocols?

The Dorninger systematic review found that most Shoemaker Protocol treatment steps cost $100 or less per month. MoldCo's typical all-in monthly cost runs $150 to $300, covering care, medication, and provider access over a 6 to 12 month protocol.

Compare that with supplement-heavy approaches where patients report spending thousands per year on products that may not address the root mechanism. The cost difference compounds over time, especially when the supplement stack keeps growing.

If you want to see whether this approach fits your situation, take the symptom questionnaire first. It's free and takes a few minutes.

Can I start binders even if I'm still in a moldy environment?

Yes. MoldCo supports beginning binder therapy while still in a moldy or borderline environment. You don't have to "get out first, then treat."

Binders work in the gut regardless of whether you're still being exposed. They won't fix the environmental problem, but they can help reduce your toxic burden while you work on remediation or relocation.

For practical guidance on what to expect once you start, see our guide on managing binder side effects.

Fewer supplements. A clear mechanism. Clinician-supervised steps, sequenced in the right order.

If you've been stacking products without clear progress, this might be the explanation you've been looking for. Rule it in or rule it out: start your evaluation.

Any health-related claims made on this site have not been evaluated by the Food and Drug Administration (FDA). The information provided on this site is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. MoldCo assumes no responsibility or liability for any errors or omissions in the content of the references, nor for any actions taken in reliance thereon.